The EU AI Act Digital Omnibus is stuck, not because of broad disagreement, but because of a specific technical dispute that has proven harder to resolve than anyone anticipated. Reuters confirmed that EU member states and the European Parliament failed to reach agreement after approximately 12 hours of negotiations, with Germany leading a bloc of member states seeking to weaken compliance obligations for manufacturers of regulated products that happen to contain AI.
The sticking point is product safety exemptions. Germany and allied member states want AI embedded in CE-marked products, medical devices, machinery, toys, cars, to be governed primarily by existing product safety regulations rather than the EU AI Act’s Annex III high-risk framework. The European Parliament has resisted. Politico EU reports the dispute centers on requests to weaken rules for manufacturing and medical devices specifically, sectors where Germany has significant industrial exposure.
This matters because the exemption question isn’t academic. AI systems embedded in regulated medical devices or industrial machinery are among the most consequential high-risk deployments in the Annex III scope. Weakening their obligations would create a two-track compliance system: one for standalone AI applications, another for AI embedded in physical products. Organizations that manufacture or deploy AI in medical or industrial contexts need to know which track applies to them, and right now, that’s unresolved.
IAPP confirmed the stall and noted the compliance deadline pressure. The August 2, 2026 deadline for high-risk AI systems under Annex III is established in the EU AI Act text and has not been formally amended. The Omnibus would have reportedly extended it to December 2, 2027, a 16-month deferral that compliance teams had been watching closely. That extension is not in effect, and it won’t be unless talks succeed.
Per reports, a resumption of negotiations is expected in mid-May. That window is narrow. Even if political agreement is reached, formal legislative process takes time, and Computerworld has reported that some lawmakers warn of significant disruption if high-risk compliance obligations take effect before harmonized technical standards from CEN-CENELEC are finalized, a process that may not conclude until late 2026.
Robinson & Cole LLP advises compliance teams to treat August 2, 2026 as a hard deadline pending further legislative developments. That framing has logic behind it: the only thing that changes the August 2 date is a formal legislative amendment, and one isn’t in place.
What compliance teams need to track isn’t just whether talks resume, it’s whether the specific product safety exemption dispute gets resolved. A deal that excludes medical devices and industrial AI from Annex III produces a very different compliance landscape than a deal that keeps them in. The sticking point is the substance.
Whether the mid-May window produces a deal, and on what terms, is the compliance planning question for every organization in the Annex III scope this month.